at the University of Massachusetts Boston

Housed in the Integrated Sciences Complex, the Center for Personalized Cancer Therapy (CPCT) is a collaborative venture between the University of Massachusetts Boston and the Dana Farber/Harvard Cancer Center (DF/HCC).

The CPCT research team helps investigators and clinicians analyze samples, identify genetic variants contributing to disease risk, and reveal complex mechanisms involved in human disease.

Read About Us
The CPCT will develop RNA biomarkers useful for tumor subtyping and earlier detection of tumor response to therapy.